Literature DB >> 1028239

Chemotherapy of malignant glioma with CCNU alone and CCNU combined with vincristine sulfate and procarbazine hydrochloride.

W R Shapiro, D F Young.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 1028239

Source DB:  PubMed          Journal:  Trans Am Neurol Assoc        ISSN： 0065-9479


× No keyword cloud information.
  6 in total

Review 1.  Nitrosoureas in the Management of Malignant Gliomas.

Authors:  Alba A Brandes; Marco Bartolotti; Alicia Tosoni; Enrico Franceschi
Journal:  Curr Neurol Neurosci Rep       Date:  2016-02       Impact factor: 5.081

2.  Current clinical management of patients with glioblastoma.

Authors:  Stephen Lowe; Krishna P Bhat; Adriana Olar
Journal:  Cancer Rep (Hoboken)       Date:  2019-09-04

Review 3.  Procarbazine, lomustine and vincristine for recurrent high-grade glioma.

Authors:  Saurabh Parasramka; Goutham Talari; Myrna Rosenfeld; Jing Guo; John L Villano
Journal:  Cochrane Database Syst Rev       Date:  2017-07-26

4.  Combined surgery, radiation, and PCV chemotherapy for astrocytomas compared to oligodendrogliomas and oligoastrocytomas WHO grade III.

Authors:  Rudolf A Kristof; Georg Neuloh; Volkmar Hans; Martina Deckert; Horst Urbach; Uwe Schlegel; Matthias Simon; Johannes Schramm
Journal:  J Neurooncol       Date:  2002-09       Impact factor: 4.130

5.  Phase III randomized trial comparing the efficacy of cediranib as monotherapy, and in combination with lomustine, versus lomustine alone in patients with recurrent glioblastoma.

Authors:  Tracy T Batchelor; Paul Mulholland; Bart Neyns; L Burt Nabors; Mario Campone; Antje Wick; Warren Mason; Tom Mikkelsen; Surasak Phuphanich; Lynn S Ashby; John Degroot; Rao Gattamaneni; Lawrence Cher; Mark Rosenthal; Franz Payer; Juliane M Jürgensmeier; Rakesh K Jain; A Gregory Sorensen; John Xu; Qi Liu; Martin van den Bent
Journal:  J Clin Oncol       Date:  2013-08-12       Impact factor: 44.544

6.  Assay of anti-cancer drugs in tissue culture: relationship of relapse free interval (RFI) and in vitro chemosensitivity in patients with malignant cerebral glioma.

Authors:  D G Thomas; J L Darling; E A Paul; T J Mott; J N Godlee; J S Tobias; L G Capra; C D Collins; C Mooney; T Bozek
Journal:  Br J Cancer       Date:  1985-04       Impact factor: 7.640
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.